Cernevit inj./inf. sol. (pwdr.) i.m./i.v. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Nicotinamide 46 mg/5 ml; Cocarboxylase Tetrahydrate 5,8 mg/5 ml; Riboflavin Sodium Phosphate 5,67 mg/5 ml; Pyridoxine Hydrochloride 5,5 mg/5 ml; Retinol Palmitate 3500 IU/5 ml; Ascorbic Acid 125 mg/5 ml; Biotin 0,069 mg/5 ml; Dexpanthenol 16,15 mg/5 ml; Cyanocobalamin 0,006 mg/5 ml; Cholecalciferol 220 IU/5 ml; Folic Acid 0,414 mg/5 ml; Alfa-Tocoferol 10,2 mg/5 ml

Available from:

Baxter SA-NV

ATC code:

B05XC

INN (International Name):

Dexpanthenol; Cholecalciferol; Cyanocobalamin; Cocarboxylase; Folic Acid; Nicotinamide; Riboflavin Sodium Phosphate; Retinol Palmitate; Pyridoxine Hydrochloride; Tocopherol-DL-Alfa; Biotin; Ascorbic Acid

Pharmaceutical form:

Powder for solution for injection/infusion

Composition:

Dexpanthenol 16.15 mg; Cholecalciferol 220 IU; Cyanocobalamin 6 µg; Cocarboxylase 5.8 mg; Folic Acid 0.41 mg; Nicotinamide 46 mg; Riboflavin Sodium Phosphate 5.67 mg; Retinol Palmitate 3500 IU; Pyridoxine Hydrochloride 5.5 mg; Tocopherol-DL-Alfa 10.2 mg; Biotin 0.07 mg; Ascorbic Acid 125 mg

Administration route:

Intramuscular use; Intravenous use

Therapeutic area:

Vitamins

Product summary:

CTI code: 152223-01 - Pack size: 1 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 152223-03 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 152223-02 - Pack size: 10 - Commercialisation status: YES - FMD code: 05413760053981 - CNK code: 0284463 - Delivery mode: Medical prescription

Authorization status:

Commercialised: Yes

Authorization date:

1990-08-16